ZLD ASX Chart
Snapshot
Zelira Therapeutics Limited (ZLD) is a biopharmaceutical company in the research, development, and commercialization of cannabinoid-based medicines. The company owns a portfolio of products and a pipeline of candidates undergoing development positioned to enter markets. It is focused on developing and validating cannabinoid-based medicines in its prescription (Rx) business for the treatment of medical conditions including insomnia, autism, and chronic non-cancer pain, as well as offering over the counter (OTC) products.Zelira Therapeutics Limited (ZLD) is a biopharmaceutical company in the research, development, and commercialization of cannabinoid-based medicines. The company owns a portfolio of products and a pipeline of candidates undergoing development positioned to enter markets. It is focused on developing and validating cannabinoid-based medicines in its prescription (Rx) business for the treatment of medical conditions including insomnia, autism, and chronic non-cancer pain, as well as offering over the counter (OTC) products.
Share Price Activity (ASX)
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2026 YTD | |
| 1 Year | |
| vs Sector (1yr) | +58.25% |
| vs ASX 200 (1yr) | +19.43% |
Announcements
Corporate Overview
Corporate Details
| Head Office | Perth WA 6000 |
| Website | www.zeliratx.com |
| Registry | Computershare |
| Auditor | Hall Chadwick WA Audit Pty Ltd |
| Date Listed | 28 Jul 2003 |
Upcoming Calendar (Forecasted)
| Date | Event |
|---|---|
| 28/08/2026 | Report (Prelim) |
| 25/09/2026 | Report (Annual) |
Former Company Names
- Zelda Therapeutics Limited (ZLD), 04/12/2019
- Gleneagle Gold Limited (GLN), 10/10/2016
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
ZLD directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of ZLD directors.
Shareholder Info
Substantial Shareholders
No Substantial Shareholders for ZLD in our database.
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2025 | $0.44 | 30 June |
| 2024 | $0.28 | 28 June |
| 2023 | $1.51 | 30 June |
| 2022 | $0.97 | 30 June |
| 2021 | $0.043 | 30 June |
| 2020 | $0.054 | 30 June |
| 2019 | $0.04 | 28 June |
| 2018 | $0.09 | 29 June |
| 2017 | $0.074 | 30 June |
| 2016 | $0.005 | 30 June |
| 2015 | $0.003 | 30 June |
| 2014 | $0.002 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.